Drug Pipeline Progress: Positive clinical trial results for key drug candidates in Legend Biotech's pipeline can significantly boost investor confidence and drive the stock price up. Conversely, setbacks or failures in trials can lead to a decline. Regulatory Approvals: Receiving approval from regulatory bodies like the FDA for new therapies is a major catalyst for stock appreciation, as it opens up market access and revenue potential. Delays or rejections can negatively impact the stock. Market Competition: The competitive landscape in the multiple myeloma treatment space influences Legend Biotech's pricing power and market share. Strong competition from established players or novel therapies can put downward pressure on the stock. Financial Performance: Legend Biotech's revenue, profitability, and cash flow directly affect investor sentiment. Strong financial results typically lead to positive stock performance, while weak performance can trigger a sell-off. Overall Market Conditions: Broader economic trends and market sentiment can impact all stocks, including LGND.US. Bull markets tend to lift stock prices, while bear markets can drag them down, regardless of company-specific factors.